Science

04/29/24

Now boarding: Net-zero aviation

Policy

Science

Planetary

04/25/24

RAVen’s Project Condor fights flu with Cidara deal

Biotech

Finance

Science

09/19/23

Why we’re stuck on Hyku Biosciences

Biotech

Finance

Science

12/21/22

What you were reading — RApport’s 2022 Top Ten

Culture

Finance

Policy

Science

12/12/22

FutureCast | Back to the future: How old drugs are enabling new discoveries and a new era for treating depression

Biotech

Science

08/24/22

GoodRx collaborating with RA Capital on Survey to Better Understand Patient Assistance Programs

Science

06/10/22

72 hours to kill: Why can’t we diagnose bacterial infections faster?

Biotech

Science

04/20/22

Nektar’s IL‑2 legacy: The two sides of failure

Biotech

Science

04/19/22

Announcing Sionna: When it comes to Cystic Fibrosis, ​“good enough” isn’t good enough

Biotech

Science

10/19/21

Vaccines and the inverted capital dilemma

Biotech

Culture

Finance

Science

10/12/21

Rational design of molecular glues — the next frontier

Biotech

Science

09/30/21

Innovation thrives in the spotlight

Biotech

Culture

Science

09/13/21

RA TV: Past, present, & future

Biotech

Science

09/09/21

And now for something completely different

Biotech

Culture

Science

08/26/21

RA TV: Aduhelm & Patient-Centered Healthcare Reforms

Biotech

Policy

Science

07/22/21

Accelerating life science tools R&D with venture studios

Biotech

Culture

Finance

Science

07/08/21

RA TV: Vaccines versus variants

Biotech

Science

06/02/20

It’s time to bring generic drug manufacturing back to the U.S.

Biotech

Policy

Science